Kimberly Bridges
Family Medicine · Landrum, SCNPI 1659342319
Payments from drug & device makers
Across 418 payments — averaging $15.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$748
- AstraZeneca$674
- GSK$442
- Amgen$421
- Lilly USA, LLC$378
- Johnson & Johnson$347
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,34898%
- Education$1002%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 57 | $748 |
| AstraZeneca(2 entities) | 46 | $674 |
| GSK | 31 | $442 |
| Amgen | 26 | $421 |
| Lilly USA, LLC | 28 | $378 |
| Johnson & Johnson | 29 | $347 |
| Pfizer | 21 | $308 |
| Novo Nordisk | 19 | $294 |
| Merck | 16 | $274 |
| Abbott | 13 | $254 |
| Boehringer Ingelheim | 17 | $253 |
| Astellas Pharma US Inc | 9 | $252 |
| Sanofi-aventis U.S. LLC | 14 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $215 |
| Eisai Inc. | 13 | $209 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $170 |
| Amarin Pharma, Inc. | 11 | $155 |
| Bayer | 7 | $108 |
| Esperion Therapeutics, Inc. | 5 | $94 |
| Daiichi Sankyo Inc. | 4 | $81 |
| Novartis | 4 | $66 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Biocryst US Sales Co., LLC | 1 | $55 |
| Exact Sciences | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $25 |
| Inari Medical, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Medicure Pharma Inc. | 1 | $13 |
| Therapeuticsmd, Inc. | 1 | $11 |
How this compares
$6,448 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $48,518 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $20,186 |
| JardianceEmpagliflozin | 14 | $16,501 |
| TrulicityDulaglutide | 12 | $15,127 |
| OzempicSemaglutide | 15 | $12,957 |
| XareltoRivaroxaban | 12 | $11,954 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $10,468 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $2,543 |
| Dexlansoprazole DrDexlansoprazole | 11 | $2,070 |
| Rosuvastatin Calcium | 130 | $1,455 |
| Pantoprazole Sodium | 118 | $1,225 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $1,176 |
| SynthroidLevothyroxine Sodium | 11 | $1,083 |
| Atorvastatin Calcium | 145 | $1,011 |
| Levothyroxine Sodium | 153 | $970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $308 | $48,51852 claims |
| GSKTrelegy Ellipta | $442 | $20,18624 claims |
| Boehringer IngelheimJardiance | $253 | $16,50114 claims |
| Lilly USA, LLCTrulicity | $378 | $15,12712 claims |
| Novo NordiskOzempic | $294 | $12,95715 claims |
| Johnson & JohnsonXarelto | $347 | $11,95412 claims |
| AbbVieSynthroid | $748 | $1,08311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Landrum
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.